Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy - related renal failure

QJM

Volumn 69, Issue 1, 1988, Pages 795-815

  Kincaid Smith, Priscilla ^a,b,c   Fairley, Kenneth F ^a,b,c   Kloss, Michael ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; LUPUS ANTICOAGULANT; ANTICOAGULANT AGENT;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; KIDNEY; MICROCIRCULATION; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RECURRENT ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VASCULARIZATION; EXCHANGE BLOOD TRANSFUSION; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; BLOOD COAGULATION FACTORS; FEMALE; HUMAN; KIDNEY; KIDNEY FAILURE, ACUTE; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICROCIRCULATION; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOSIS;

EID: 0024093065     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/oxfordjournals.qjmed.a068246     Document Type: Article

References (30)

1. Kincaid-Smith P. A case of many lesions. Demonstrated at the Postgraduate Medical School of London. Clinicopathological Conference. Br Med J 1959; 1: 224-229.
2. Kant KS, Pollak VE, Weiss MA, et al. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine 1981; 60: 71-86.
3. Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985; 145: 1389-1395.
4. Feinstein DI. Lupus anticoagulant. Thrombosis and fetal loss. N Engl J Med 1985; 313: 1348-1350.
5. Bowie EJ, Thompson JH, Pascuzzi CA, Owen CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430.
6. Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus ‘anticoagulant’. Ann Intern Med 1980; 92: 156-159.
7. Boey ML, Colaco CB, Gharavi AE, Elkin KB, Loizou S, Hughes GRV. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus ‘anticoagulant’. Br Med J 1983; 287: 1021-1023.
8. Elias M, Eldor A. Thromboembolism in patients with the ‘lupus’-type circulating anticoagulant. Arch Intern Med 1984; 144: 510-515.
9. Harris EN, Gharavi AE, Boey ML et al. Anticardiolipid antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214.
10. Bhathena DB, Sobel BJ, Migdal SD. Noninflammatory renal microangiopathy of systemic lupus erythematosus (‘lupus vasculitis’). Am J Nephrol 1981; 1: 144-159.
11. Buchanan RRC, Wardlaw JR, Travers DC. An enzyme linked immunosorbent assay (ELISA) for the measurement of anti-cardiolipin antibodies within human sera: The importance of non specific binding and differences in antibody specificity between systemic lupus erythematosus and rheumatoid arthritis. In press.
12. Heptinstall RH. Pathology of the kidney. 3rd edn. Vol 2. Boston: Little, Brown & Co, 1983: 915.
13. Kincaid-Smith P. The kidney: a clinicopathological study. Oxford: Blackwell Scientific Publications, 1975: 240.
14. Kincaid-Smith P. The pathogenesis of the vascular and glomerular lesions of rejection in renal allografts and their modification by antithrombotic and anticoagulant drugs. A’Asian Ann Med 1970; 19: 201-214.
15. Lockshin MD, Harpel PC, Druzin ML, et al. Lupus pregnancy. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient. Arthritis Rheum 1985; 28: 58-66.
16. Kincaid-Smith P. Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Int 1975; 7: 242-253.
17. Heptinstall RH. Pathology of the kidney. 3rd edn. Vol. 2. Boston: Little, Brown & Co, 1983: 907.
18. Courtecuisse V, Habib R, Mounier C. Non-lethal haemolytic and uraemic syndromes in children - an electron microscopic study of renal biopsies in 6 cases. Exp Mol Pathol 1967; 7: 327-347.
19. Carreras LO, Vermylen J, Spitz B, Van Assche A. Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981; 88: 890-894.
20. Remuzzi G, Mecca G, Livio M, et al. Prostacyclin generation by cultured endothelial cells in haemolytic uraemic syndrome. Lancet 1980; 1: 656-657.
21. Robson JS, Martin AM, Ruchley VA, Macdonald MK. Irreversible post-partum renal failure. QJMed 1968; 37: 423.
22. Kincaid-Smith P. The similarity of lesions and underlying mechanism in pre-eclamptic toxaemia and post-partum renal failure. Studies in the acute stage and during follow-up. In: Kincaid-Smith P, Mathew TH, Becker EL, Glomerulonephritis. New York: John Wiley 1973: 1013-1025.
23. Lewis PJ, Boylan P, Friedman LA, Hensby CN, Downing I. Prostacyclin in pregnancy. Br Med J 1980; 280: 1581-1582.
24. Remuzzi G, Marchesi G, Mecca G, Mistani R, Rossi E, Donati MB. Reduction of fetal vascular prostacyclin activity in pre-eclampsia. Lancet 1980; 2:310.
25. Elias M, Eldor A. Thromboembolism in patients with the ‘lupus type’ circulating anticoagulant. Arch Intern Med 1984; 144: 510-515.
26. Branch DW, Scott JP, Kochenour NK, Hershgold E. Obstetric complications associated with lupus anticoagulant. N Engl J Med 1985; 313: 1322-1326.
27. De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829-834.
28. Robertson WB, Brosens I, Dixon G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. In: Lindheimer MD, Katz AI, Zuspan FE, eds. Hypertension in pregnancy. New York: John Wiley, 1976: 115.
29. Manoharan A, Gottlieb P. Bleeding in patients with lupus anticoagulant. Lancet 1984; 2: 171.
30. Ordi J, Vilardel M, Oristrell J, et al. Bleeding in patients with lupus anticoagulant. Lancet 1984; 2: 171.